Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
Intended for Healthcare Professionals
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Clinical Practice

Prophylactic macrolides for chronic obstructive pulmonary disease in the community: a decision for GPs

Sarah Fennelly, Jennifer Bruton and Walter Cullen
British Journal of General Practice 2022; 72 (714): 42-43. DOI: https://doi.org/10.3399/bjgp22X718253
Sarah Fennelly
HDip University Teaching & Learning, professor of urban general practice, School of Medicine, University College Dublin, Dublin.
Roles: Medical student
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Bruton
HDip University Teaching & Learning, professor of urban general practice, School of Medicine, University College Dublin, Dublin.
Roles: Medical student
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Cullen
HDip University Teaching & Learning, professor of urban general practice, School of Medicine, University College Dublin, Dublin.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading

Chronic obstructive pulmonary disease (COPD) is a common progressive respiratory condition with a heavy symptom burden and was the third leading cause of death worldwide in 2019.1 One tool in the GP’s arsenal is prophylactic antibiotics, with macrolides being the most effective. These are thought to both reduce the frequency of infective exacerbations via the antimicrobial effect of neutrophil activation and combat excessive airway inflammation by induction of T helper type 1 lymphocytes, which act to combat inflammation and cause thinning of the bacterial biofilm.2 The benefits of macrolides have been proven, but which patients are most likely to benefit from them, and which healthcare providers are best placed to identify them?

PATIENTS WITH MILD OR SEVERE DISEASE

The first question to explore is whether prophylactic macrolide use could be of most benefit to those with mild COPD or those with moderate-to-severe disease. A meta-analysis examining the effect of macrolide prophylaxis in the moderate-to-severe disease cohort has shown a significant reduction in the number of exacerbations with macrolide use versus placebo across all 14 studies examined.3 Furthermore, six of seven studies within this analysis showed the time to first exacerbation was significantly lengthened in the treatment groups.3 However, participants who had already been experiencing exacerbations requiring hospitalisation showed no significant reduction in …

View Full Text

  RCGP login

Members, please Login at RCGP to access the journal online.

  Subscriber login

Enter your BJGP login information below.

Log in using your username and password

Enter your British Journal of General Practice username.
Enter the password that accompanies your username.
Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

  Subscribe

Subscribe to the Journal - Subscribe to the print and/or online journal.

Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 72 (714)
British Journal of General Practice
Vol. 72, Issue 714
January 2022
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prophylactic macrolides for chronic obstructive pulmonary disease in the community: a decision for GPs
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prophylactic macrolides for chronic obstructive pulmonary disease in the community: a decision for GPs
Sarah Fennelly, Jennifer Bruton, Walter Cullen
British Journal of General Practice 2022; 72 (714): 42-43. DOI: 10.3399/bjgp22X718253

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Prophylactic macrolides for chronic obstructive pulmonary disease in the community: a decision for GPs
Sarah Fennelly, Jennifer Bruton, Walter Cullen
British Journal of General Practice 2022; 72 (714): 42-43. DOI: 10.3399/bjgp22X718253
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • PATIENTS WITH MILD OR SEVERE DISEASE
    • PATIENTS WITH COEXISTING ASTHMA
    • PATIENTS WITH GENERAL COMORBIDITIES
    • CONCLUSION
    • Notes
    • REFERENCES
  • Figures & Data
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • NICE chronic primary pain guidelines: what the busy GP needs to know
  • Realising the potential of home blood pressure monitoring in the community: should HBPM be the default?
  • Atrial fibrillation: NICE 2021 update and the focus on anticoagulation
Show more Clinical Practice

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2022 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242